RAS Blockade May Not Stop CKD Progression
MORE THAN HALF of African Americans with hypertensive CKD will experience renal disease progression long-term despite tight BP control with drugs that block the renin-angiotensin system (RAS).
Your Email Address:
Recipient(s) Email Address:
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
Include a message (optional):
The e-mail address(es) that you supply to use this service will only be used to send the requested article.